Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheila Weinmann

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
Urology|June 16, 2018
The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause MortalityLauren P Wallner, Julia R DiBello, Bonnie H Li, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|November 28, 2021
Mammary collagen is under reproductive control with implications for breast cancerQiuchen Guo, Duanchen Sun, Alexander S Barrett, et al.
Pediatrics|June 12, 2019
Incidence of Herpes Zoster Among Children: 2003-2014Sheila Weinmann, Allison L Naleway, Padma Koppolu, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 8, 2019
The effect of multiple recruitment contacts on response rates and patterns of missing data in a survey of bladder cancer survivors 6 months after cystectomyJoanna E Bulkley, Maureen O'Keeffe-Rosetti, Christopher S Wendel, et al.
The Lancet. Oncology|October 14, 2022
Treatment-related thoracic soft tissue sarcomas in US breast cancer survivors: a retrospective cohort studyLene H S Veiga, Jacqueline B Vo, Rochelle E Curtis, et al.
Mayo Clinic Proceedings|January 28, 2017
5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic HyperplasiaLauren P Wallner, Julia R DiBello, Bonnie H Li, et al.
Journal of the National Cancer Institute|October 21, 2004
Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?Stephen H Taplin, Laura Ichikawa, Marianne Ulcickas Yood, et al.
JNCI Cancer Spectrum|May 18, 2022
Mammographic Density Decline, Tamoxifen Response, and Prognosis by Molecular Characteristics of Estrogen Receptor-Positive Breast CancerMustapha Abubakar, Maeve Mullooly, Sarah Nyante, et al.
Journal of Personalized Medicine|November 27, 2021
Feasibility of a Traceback Approach for Using Pathology Specimens to Facilitate Genetic Testing in the Genetic Risk Analysis in Ovarian Cancer (GRACE) Study ProtocolTia L Kauffman, Yolanda K Prado, Ana A Reyes, et al.
Radiation Research|September 10, 2025
Trends in Dose to the Contralateral Breast from Breast Cancer Radiotherapy in the United StatesChoonsik Lee, David Borrego, Lene H S Veiga, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
Urology|June 16, 2018
The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause MortalityLauren P Wallner, Julia R DiBello, Bonnie H Li, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|November 28, 2021
Mammary collagen is under reproductive control with implications for breast cancerQiuchen Guo, Duanchen Sun, Alexander S Barrett, et al.
Pediatrics|June 12, 2019
Incidence of Herpes Zoster Among Children: 2003-2014Sheila Weinmann, Allison L Naleway, Padma Koppolu, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 8, 2019
The effect of multiple recruitment contacts on response rates and patterns of missing data in a survey of bladder cancer survivors 6 months after cystectomyJoanna E Bulkley, Maureen O'Keeffe-Rosetti, Christopher S Wendel, et al.
The Lancet. Oncology|October 14, 2022
Treatment-related thoracic soft tissue sarcomas in US breast cancer survivors: a retrospective cohort studyLene H S Veiga, Jacqueline B Vo, Rochelle E Curtis, et al.
Mayo Clinic Proceedings|January 28, 2017
5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic HyperplasiaLauren P Wallner, Julia R DiBello, Bonnie H Li, et al.
Journal of the National Cancer Institute|October 21, 2004
Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?Stephen H Taplin, Laura Ichikawa, Marianne Ulcickas Yood, et al.
JNCI Cancer Spectrum|May 18, 2022
Mammographic Density Decline, Tamoxifen Response, and Prognosis by Molecular Characteristics of Estrogen Receptor-Positive Breast CancerMustapha Abubakar, Maeve Mullooly, Sarah Nyante, et al.
Journal of Personalized Medicine|November 27, 2021
Feasibility of a Traceback Approach for Using Pathology Specimens to Facilitate Genetic Testing in the Genetic Risk Analysis in Ovarian Cancer (GRACE) Study ProtocolTia L Kauffman, Yolanda K Prado, Ana A Reyes, et al.
Radiation Research|September 10, 2025
Trends in Dose to the Contralateral Breast from Breast Cancer Radiotherapy in the United StatesChoonsik Lee, David Borrego, Lene H S Veiga, et al.
Pageof 11